Alicia Baumgartner

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of Bevacizumab treatment intervals on surgical interventions in pediatric neuro-oncology.

Impact of Bevacizumab treatment intervals on surgical interventions in pediatric neuro-oncology.

Journal: Neuro-oncology advances

Published: August 27, 2025

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Journal: Neuro-oncology

Published: November 18, 2024

Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.

Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.

Journal: Acta neuropathologica

Published: October 07, 2024

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Journal: Nature cancer

Published: August 24, 2024

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Journal: Cancer cell

Published: July 30, 2024

Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure.

Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure.

Journal: Cell reports. Medicine

Published: June 21, 2023

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

Journal: Cancers

Published: March 04, 2023

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.

Journal: Cancers

Published: September 21, 2022

Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.

Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.

Journal: Journal of personalized medicine

Published: March 19, 2021

Resolving medulloblastoma cellular architecture by single-cell genomics.

Resolving medulloblastoma cellular architecture by single-cell genomics.

Journal: Nature

Published: September 13, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026